Hospitalist Doctors in Salem, OR Accepting Medicare

9 Hospitalist doctors found. Showing 1 - 9

Dr. Mojabeng Phoofolo, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 890 Oak St Se, Salem, OR 97301 Phone: 503-561-5200

Sandra Kurup, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 890 Oak St Se, Salem, OR 97301 Phone: 503-561-5200

Dr. Syed Muzamil Hussain Zaidi, M.B.B.S Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 890 Oak St Se, Salem, OR 97301 Phone: 503-561-5200

Basma Saadoun, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2020 Capitol St Ne, Salem, OR 97301 Phone: 503-399-2424

Dr. Chuong Huan Nguyen, Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2400 Lancaster Dr Ne, Salem, OR 97305 Phone: 503-370-4825

Natalie Ann Melrose, M.S., M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 665 Winter St Se, Salem, OR 97301 Phone: 503-561-5200

Urvi Mevar, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 890 Oak St Se, Salem Hospital, Salem, OR 97301 Phone: 503-561-5200

Dr. Thong Lac Khuu, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 890 Oak St Se, Bldg B, Salem, OR 97301 Phone: 503-561-5290

Daniel Lewis Roth, M.D Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 665 Winter St Se, Salem, OR 97301 Phone: 503-561-5356

News Archive

New therapy strategy for liver disease shows initial measureable success with norUrso

The new therapy strategy for primary sclerosing cholangitis, a liver disease that at present still cannot be cured with medication, shows initial measureable success with the nor-ursodeoxycholic acid (norUrso).

NeoRx Corporation acquires worldwide rights to platinum-based anti-cancer agent

NeoRx Corporation today announced that it has acquired from AnorMED Inc. the worldwide exclusive rights, excluding Japan, to develop, manufacture and commercialize AMD473, a platinum-based anti-cancer agent. AMD473 has been administered to more than 500 cancer patients in phase I and phase II clinical trials, demonstrating anti-cancer activity in a wide range of tumors and a manageable safety profile. NeoRx expects to initiate clinical studies of AMD473 in one or more cancer indications in the second half of this year.

Rebooting and reprogramming the brain

Does the brain you were born with have to be the brain you end up with? If you can improve the function of every major organ in the body, why can't you upgrade the function of your brain? Those fundamental questions were the motivation that led Kelly Howell to create Brain Sync.

Patients denied admission to intensive care because of doctors' pessimism

Doctors are overly pessimistic about the chances of survival for patients with COPD related attacks and, as a result, some patients may be denied admission to hospital for vital help, according to a study published on bmj.com.

Semprus BioSciences to develop surface-modified endotracheal tube

Teleflex Incorporated, a leading global provider of medical devices for critical care and surgery, has announced that Semprus BioSciences, a wholly owned subsidiary of Teleflex Incorporated, has been awarded the initial phase of a $2.3 million research grant from the U.S. Army's Telemedicine and Advanced Technology Research Center (TATRC), located at Fort Detrick, MD.

Read more Medical News

› Verified 7 days ago